JP2010504301A5 - - Google Patents

Download PDF

Info

Publication number
JP2010504301A5
JP2010504301A5 JP2009528719A JP2009528719A JP2010504301A5 JP 2010504301 A5 JP2010504301 A5 JP 2010504301A5 JP 2009528719 A JP2009528719 A JP 2009528719A JP 2009528719 A JP2009528719 A JP 2009528719A JP 2010504301 A5 JP2010504301 A5 JP 2010504301A5
Authority
JP
Japan
Prior art keywords
cycloalkyl
attached
compound according
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009528719A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010504301A (ja
Filing date
Publication date
Priority claimed from GB0618776A external-priority patent/GB0618776D0/en
Priority claimed from GB0704012A external-priority patent/GB0704012D0/en
Priority claimed from GB0717170A external-priority patent/GB0717170D0/en
Application filed filed Critical
Priority claimed from PCT/EP2007/059933 external-priority patent/WO2008034860A1/en
Publication of JP2010504301A publication Critical patent/JP2010504301A/ja
Publication of JP2010504301A5 publication Critical patent/JP2010504301A5/ja
Pending legal-status Critical Current

Links

JP2009528719A 2006-09-22 2007-09-20 Ikk2阻害物質としてのピロロ[2,3−b]ピリジン−4−イル−ベンゼンスルホンアミド化合物 Pending JP2010504301A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB0618776A GB0618776D0 (en) 2006-09-22 2006-09-22 Novel compounds
GB0704012A GB0704012D0 (en) 2007-03-01 2007-03-01 Novel compounds
GB0717170A GB0717170D0 (en) 2007-09-04 2007-09-04 Novelcompounds
PCT/EP2007/059933 WO2008034860A1 (en) 2006-09-22 2007-09-20 Pyrrolo[2, 3-b]pyridin-4-yl-benzenesulfonamide compounds as ikk2 inhibitors

Publications (2)

Publication Number Publication Date
JP2010504301A JP2010504301A (ja) 2010-02-12
JP2010504301A5 true JP2010504301A5 (cg-RX-API-DMAC7.html) 2010-11-18

Family

ID=39092148

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009528719A Pending JP2010504301A (ja) 2006-09-22 2007-09-20 Ikk2阻害物質としてのピロロ[2,3−b]ピリジン−4−イル−ベンゼンスルホンアミド化合物

Country Status (11)

Country Link
US (3) US20100035917A1 (cg-RX-API-DMAC7.html)
EP (1) EP2069341B1 (cg-RX-API-DMAC7.html)
JP (1) JP2010504301A (cg-RX-API-DMAC7.html)
AR (1) AR062928A1 (cg-RX-API-DMAC7.html)
AT (1) ATE493411T1 (cg-RX-API-DMAC7.html)
CL (1) CL2007002708A1 (cg-RX-API-DMAC7.html)
DE (1) DE602007011645D1 (cg-RX-API-DMAC7.html)
PE (1) PE20080925A1 (cg-RX-API-DMAC7.html)
TW (1) TW200836724A (cg-RX-API-DMAC7.html)
UY (1) UY30600A1 (cg-RX-API-DMAC7.html)
WO (1) WO2008034860A1 (cg-RX-API-DMAC7.html)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0400895D0 (en) * 2004-01-15 2004-02-18 Smithkline Beecham Corp Chemical compounds
PE20060373A1 (es) * 2004-06-24 2006-04-29 Smithkline Beecham Corp Derivados 3-piperidinil-7-carboxamida-indazol como inhibidores de la actividad cinasa de ikk2
US8063071B2 (en) 2007-10-31 2011-11-22 GlaxoSmithKline, LLC Chemical compounds
AR065804A1 (es) 2007-03-23 2009-07-01 Smithkline Beecham Corp Compuesto de indol carboxamida, composicion farmaceutica que lo comprende y uso de dicho compuesto para preparar un medicamento
GB0804592D0 (en) * 2008-03-12 2008-04-16 Glaxo Group Ltd Novel compounds
GB0804591D0 (en) * 2008-03-12 2008-04-16 Glaxo Group Ltd Novel compounds
WO2010025236A1 (en) * 2008-08-27 2010-03-04 Alexander Goldin Composition and method for treating colds
WO2010102968A1 (en) 2009-03-10 2010-09-16 Glaxo Group Limited Indole derivatives as ikk2 inhibitors
WO2012088266A2 (en) 2010-12-22 2012-06-28 Incyte Corporation Substituted imidazopyridazines and benzimidazoles as inhibitors of fgfr3
US8877742B2 (en) 2011-06-10 2014-11-04 Glaxosmithkline Intellectual Property Limited Compounds
BR112014030812B1 (pt) 2012-06-13 2022-11-08 Incyte Holdings Corporation Compostos tricíclicos substituídos como inibidores de fgfr, seus usos, composição farmacêutica e método para inibir uma enzima fgfr
WO2014026125A1 (en) 2012-08-10 2014-02-13 Incyte Corporation Pyrazine derivatives as fgfr inhibitors
US9266892B2 (en) 2012-12-19 2016-02-23 Incyte Holdings Corporation Fused pyrazoles as FGFR inhibitors
AR101528A1 (es) * 2013-03-14 2016-12-28 Abbvie Inc Inhibidores de cdk9 quinasa de pirrolo[2,3-b]piridina
WO2014139328A1 (en) * 2013-03-14 2014-09-18 Abbvie Inc. Pyrrolo[2,3-b]pyridine cdk9 kinase inhibitors
ME03015B (me) 2013-04-19 2018-10-20 Incyte Holdings Corp Biciklični heterocikli kao fgfr inhibitori
US10851105B2 (en) 2014-10-22 2020-12-01 Incyte Corporation Bicyclic heterocycles as FGFR4 inhibitors
MA41551A (fr) 2015-02-20 2017-12-26 Incyte Corp Hétérocycles bicycliques utilisés en tant qu'inhibiteurs de fgfr4
WO2016134294A1 (en) 2015-02-20 2016-08-25 Incyte Corporation Bicyclic heterocycles as fgfr4 inhibitors
CR20170390A (es) 2015-02-20 2017-10-23 Incyte Holdings Corp Heterociclos biciclicos como inhibidores de fgfr
AR111960A1 (es) 2017-05-26 2019-09-04 Incyte Corp Formas cristalinas de un inhibidor de fgfr y procesos para su preparación
TW201946630A (zh) 2018-05-04 2019-12-16 美商英塞特公司 Fgfr抑制劑之鹽
SG11202010636VA (en) 2018-05-04 2020-11-27 Incyte Corp Solid forms of an fgfr inhibitor and processes for preparing the same
WO2020185532A1 (en) 2019-03-08 2020-09-17 Incyte Corporation Methods of treating cancer with an fgfr inhibitor
US11591329B2 (en) 2019-07-09 2023-02-28 Incyte Corporation Bicyclic heterocycles as FGFR inhibitors
US12122767B2 (en) 2019-10-01 2024-10-22 Incyte Corporation Bicyclic heterocycles as FGFR inhibitors
GEP20247679B (en) 2019-10-14 2024-10-10 Incyte Corp Bicyclic heterocycles as fgfr inhibitors
WO2021076728A1 (en) 2019-10-16 2021-04-22 Incyte Corporation Bicyclic heterocycles as fgfr inhibitors
AU2020395185A1 (en) 2019-12-04 2022-06-02 Incyte Corporation Derivatives of an FGFR inhibitor
EP4069696A1 (en) 2019-12-04 2022-10-12 Incyte Corporation Tricyclic heterocycles as fgfr inhibitors
WO2021146424A1 (en) 2020-01-15 2021-07-22 Incyte Corporation Bicyclic heterocycles as fgfr inhibitors
EP4323405A1 (en) 2021-04-12 2024-02-21 Incyte Corporation Combination therapy comprising an fgfr inhibitor and a nectin-4 targeting agent
CA3220155A1 (en) 2021-06-09 2022-12-15 Incyte Corporation Tricyclic heterocycles as fgfr inhibitors
TW202313611A (zh) 2021-06-09 2023-04-01 美商英塞特公司 作為fgfr抑制劑之三環雜環
CN114210133B (zh) * 2021-12-13 2023-01-24 广德辉龙环保科技有限公司 一种抗紫外线过滤袋及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030109550A1 (en) * 2001-09-19 2003-06-12 Michael Clare Substituted indazole compounds for the treatment of inflammation
GB0308466D0 (en) * 2003-04-11 2003-05-21 Novartis Ag Organic compounds

Similar Documents

Publication Publication Date Title
JP2010504301A5 (cg-RX-API-DMAC7.html)
JP2009524695A5 (cg-RX-API-DMAC7.html)
JP2010524750A5 (cg-RX-API-DMAC7.html)
JP2010505891A5 (cg-RX-API-DMAC7.html)
JP2010518805A5 (cg-RX-API-DMAC7.html)
JP2010538767A5 (cg-RX-API-DMAC7.html)
JP2012507448A5 (cg-RX-API-DMAC7.html)
JP2010500116A5 (cg-RX-API-DMAC7.html)
JP2011526809A5 (cg-RX-API-DMAC7.html)
JP2010505027A5 (cg-RX-API-DMAC7.html)
JP2009149903A5 (cg-RX-API-DMAC7.html)
JP2011528458A5 (cg-RX-API-DMAC7.html)
JP2010514554A5 (cg-RX-API-DMAC7.html)
JP2008056926A5 (cg-RX-API-DMAC7.html)
JP2009533064A5 (cg-RX-API-DMAC7.html)
JP2011508438A5 (cg-RX-API-DMAC7.html)
JP2011501007A5 (cg-RX-API-DMAC7.html)
ATE554604T1 (de) Verbesserter ohrhörer
JP2011519825A5 (cg-RX-API-DMAC7.html)
JP2010521616A5 (cg-RX-API-DMAC7.html)
JP2010529364A5 (cg-RX-API-DMAC7.html)
JP2009536652A5 (cg-RX-API-DMAC7.html)
JP2010532504A5 (cg-RX-API-DMAC7.html)
JP2013501834A5 (cg-RX-API-DMAC7.html)
JP2013529123A5 (cg-RX-API-DMAC7.html)